Skip to main content
Loading
Brenton Hamdorf

Brenton Hamdorf, MBA

Chief Executive Officer, Celosia Therapeutics Pty Ltd
Australia
Dr. Hamdorf is a biotechnology entrepreneur with extensive experience in the commercialisation of biotechnologies, with a focus on business development, partnering, intellectual property and the management of early-stage opportunities. He holds a PhD in biochemistry and molecular biology from the University of New England and an MBA from Queensland University of Technology. He is also a Registered Technology Transfer Professional (RTTP) with more than 25 years’ experience in and around the technology transfer industry and company creation.
Sessions

BIO DOUBLE HELIX SPONSOR

BIO HELIX SPONSOR

CONFERENCE SPONSORS